Eargo receives notification from nasdaq related to delayed annual report on form 10-k

San jose, calif., march 10, 2022 (globe newswire) -- eargo, inc. (nasdaq: ear) (the “company” or “eargo”), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the company received a letter from the listing qualifications department of the nasdaq stock market llc (“nasdaq”) on march 4, 2022 indicating that, because the company has not yet filed its annual report on form 10-k for the fiscal year ended december 31, 2021 (the “form 10-k”), the company does not comply with nasdaq listing rule 5250(c)(1) for continued listing.
EAR Ratings Summary
EAR Quant Ranking